Home / Drug shortages / Methylprednisolone Acetate Injection

Methylprednisolone Acetate Injection — FDA Drug Shortage

Current — Par Health, USA LLC

The FDA lists a drug shortage record for Methylprednisolone Acetate Injection (injection) from Par Health, USA LLC with status Current. The shortage was first posted on 06/16/2022. Reported reason: Demand increase for the drug

Shortage Details

Status
Current
Company
Par Health, USA LLC
Package NDC
42023-240-01
Dosage Form
Injection
Presentation
Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01)
Initial Posting
06/16/2022
Revised Date

Reason

Demand increase for the drug

FDA data resources